Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Zomedica Pharmaceuticals Corp (ZOM)

Zomedica Pharmaceuticals Corp (ZOM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 117,594
  • Shares Outstanding, K 979,950
  • Annual Sales, $ 25,190 K
  • Annual Income, $ -34,530 K
  • EBIT $ -53 M
  • EBITDA $ -49 M
  • 60-Month Beta 1.06
  • Price/Sales 4.74
  • Price/Cash Flow N/A
  • Price/Book 0.57
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.02
  • Most Recent Earnings $0.00 on 08/14/24
  • Next Earnings Date 11/07/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1170 +2.56%
on 11/08/24
0.1309 -8.33%
on 10/10/24
-0.0109 (-8.33%)
since 10/08/24
3-Month
0.1170 +2.56%
on 11/08/24
0.1620 -25.93%
on 08/13/24
-0.0292 (-19.57%)
since 08/08/24
52-Week
0.1170 +2.56%
on 11/08/24
0.2285 -47.48%
on 12/26/23
-0.0642 (-34.85%)
since 11/08/23

Most Recent Stories

More News
Zomedica, Inc. to Present at the LD Micro Main Event XVI

Presentation on Tuesday, October 3rd at 1:00 PM PTAnn Arbor, Michigan--(Newsfile Corp. - September 27, 2023) - Zomedica Corp. (NYSE American: ZOM) (the "Company") announced today that the Company is scheduled...

ZOM : 0.1200 (-1.40%)
Why Shares of Zomedica Were Zooming Monday

Investors bought back into the stock after it fell to its lowest point in two months.

ZOM : 0.1200 (-1.40%)
2 Meme Stocks That Are Still Down 50% Since February 2021

Don't jump on these bandwagons unless you're willing to lose most of your money.

BBBY : 0.0751 (-27.09%)
ZOM : 0.1200 (-1.40%)
Zomedica Acquires Assets of Leading tPEM(TM) Company Assisi Animal Health

ANN ARBOR, MI / ACCESSWIRE / July 18, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals,...

ZOM : 0.1200 (-1.40%)
Zomedica Announces New Global Manufacturing & Distribution Center

ANN ARBOR, MI / ACCESSWIRE / July 7, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals,...

ZOM : 0.1200 (-1.40%)
Zomedica Finalizes Acquisition of Veterinary Imaging Company Revo Squared

ANN ARBOR, MI / ACCESSWIRE / July 6, 2022 / Zomedica Corp. (NYSE American:ZOM) ('Zomedica' or the 'Company'), a veterinary health company offering diagnostic and therapeutic products for companion animals,...

ZOM : 0.1200 (-1.40%)
Zomedica Announces Designation of PulseVet(R) System as the Official Shock Wave Therapy Supplier of the United States Equestrian Team

ANN ARBOR, MI / ACCESSWIRE / June 28, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for equine and companion...

ZOM : 0.1200 (-1.40%)
Zomedica to Participate in Panel Discussion at Animal Health Investment Forum

ANN ARBOR, MI / ACCESSWIRE / June 21, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals,...

ZOM : 0.1200 (-1.40%)
Zomedica to Acquire Assets of Innovative Veterinary Imaging Company Revo Squared

ANN ARBOR, MI / ACCESSWIRE / June 15, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals,...

ZOM : 0.1200 (-1.40%)
Zomedica to Investigate Shock Wave Therapy of Exercised Induced Pulmonary Hemorrhage in Horses

ANN ARBOR, MI / ACCESSWIRE / June 13, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals,...

ZOM : 0.1200 (-1.40%)

Business Summary

Zomedica Corp. is a veterinary health company. It creates products for companion animals by focusing on the unmet needs of clinical veterinarians. Zomedica Corp., formerly known as Zomedica Pharmaceuticals Corp., is based in Ann Arbor, Michigan.

See More

Key Turning Points

3rd Resistance Point 0.1267
2nd Resistance Point 0.1241
1st Resistance Point 0.1221
Last Price 0.1200
1st Support Level 0.1175
2nd Support Level 0.1149
3rd Support Level 0.1129

See More

52-Week High 0.2285
Fibonacci 61.8% 0.1859
Fibonacci 50% 0.1727
Fibonacci 38.2% 0.1596
Last Price 0.1200
52-Week Low 0.1170

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar